Clinical Trials Directory

Trials / Completed

CompletedNCT06703684

TCM Syndrome Differentiation of T2DM & MetS

TCM Syndrome Differentiation of Type 2 Diabetes Comorbid With Metabolic Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
470 (actual)
Sponsor
Hong Kong Baptist University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

This study aims to include type 2 diabetes (T2DM) patients comorbid with metabolic syndrome (MetS). The primary aim of the study is to investigate the TCM (Traditional Chinese Medicine) syndrome differentiation of T2DM comorbid with MetS.

Detailed description

This study adopts a cross-sectional design, to include type 2 diabetes (T2DM) patients comorbid with metabolic syndrome (MetS). The primary aim of the study is to investigate the TCM (Traditional Chinese Medicine) syndrome differentiation of patients with T2DM and MetS. The demographic data, anthropometric data, fasting glucose and HbA1c, lipid panel, TCM syndrome differentiation information, dietary assessment, physical activity, sleep quality, and quality of life, will be assessed.

Conditions

Interventions

TypeNameDescription
OTHERCross-sectional observational studyThis is a cross-sectional observational study. No intervention will be given.

Timeline

Start date
2024-11-20
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2024-11-25
Last updated
2026-03-31

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT06703684. Inclusion in this directory is not an endorsement.